Institute for International Research

This page will be used to provide paid delegates of the conference with access to any presentations that were not included in the conference documentation. Only paid conference delegates have permission to access IIR online documentation.

While these presentations were not available to be included in your conference documentation, IIR is pleased to make them available to all conference delegates through this web site.

You will need the freely available Adobe Acrobat Reader, which is available by clicking here. To access the presentations:

• Click the title of the session
  
• You can choose to view the file online or save the file to your computer
  
• You can print the files and add them to your other conference materials

---

Monitor Liver Function in Pre-Clinical to Identify Potential Liver Toxicity in Humans
Thursday, May 17, 2007 10:45 A.M.
Michael D. DuVall, DVM, PhD Group Leader Toxicology & Safety Pharm., Global Preclinical Safety Abbott Laboratories

Advancements & Updates in Prediction Techniques
Thursday, May 17, 2007 8:45 A.M.
James W. Freston, MD, PhD Professor of Medicine Emeritus & Boehringer Ingelheim Chair of Clinical Pathology University of Connecticut Health Center

Elucidating the Role of Drug Transporters in Hepatic Toxicity
Friday, May 18, 2007 10:00 A.M.
Keith Hoffmaster, PhD Principal Scientist, ADME Biology Group Pfizer Research Technology Center

The Clinical Presentation & Evaluation of Drug-Induced Liver Injury: Is this Disease or Adaptation?
Thursday, May 17, 2007 4:00 P.M.
Christine Hunt, MD Director of Global Hepatic Safety, Clinical Safety GLAXOSMITHKLINE

Is it the Liver or Something Else? Overcome Challenges Associated with Testing for Hepatotoxicity
Thursday, May 17, 2007 2:15 P.M.
Debra Laskin, PhD Professor & Chair, Dept. of Pharmacology & Toxicology Rutgers University

Conference Chair's Opening Remarks
Thursday, May 17, 2007 8:30 A.M.
Rich Miller, DVM, PhD, DACVP VP, Safety Assessment GLAXOSMITHKLINE

A Closer Look At FDA's Current Guidance
Friday, May 18, 2007 11:15 A.M.
Yvonne Dragan Associate Director, Safety Assessment ASTRAZENECA (former FDA NCTR)